Results

Xtract Resources: Plus ca change - more delays, more ramping and more dilution (plus a Royal Ascot tip)

Published 30 days ago

I thought I would pause before commenting on yesterday’s RNS from Xtract Resources (XTR) relating to the Manica alluvials as I felt it was odds-on that more dilution would come from one source or another following the ramping off the back of it. Surprise, surprise, Yorkville cashed in and announced a loan note conversion today, but let’s take a closer look at the announcements in any event.

Advanced Oncotherapy – just what are the terms of the Bracknor funding?

Published 58 days ago

AIM-listed Advanced Oncotherapy (AVO) has this morning announced another conversion of death-spiral loan notes by Bracknor. That is not news – there have been plenty already and there are many more to come. But for the third time in succession we seem to have different terms being applied. Surely it is time for the company to tell the market what is going on?

Frontera - Why an AGM BEFORE FY numbers are released? Is the balance sheet really THAT bad?

Published 63 days ago

AIM-listed Frontera (FRR) has rather slipped since I last wrote about it last month HERE and HERE, concluding that it had a gaping black hole in its balance sheet. The shares were then trading at around 0.4p. This afternoon the shares are 0.31p in the middle (last seen) and it has announced its AGM. Just one thing: where are the full year results? The company is trying to raise c. £40 million in cash and loan settlements, and won’t show us the balance sheet? How big a RED FLAG do you want?

Advanced Oncotherapy – yet another director ponies up, EGM seemingly avoided and Bracknor converts. Most bizarre

Published 65 days ago

Well this is most bizarre! Lobster-potted Bracknor has converted another lump of its death-spiral loan notes. That, of course, is not a great surprise until you study the detail of yesterday morning’s announcement from AIM-listed Advanced Oncotherapy (AVO), where we discover that the conversion shares have been issued not at the lowest daily volume-weighted average price of the past 15 days (21.35p) as per previously announced conversion terms, but at 25p (par price of the shares). Why has Bracknor elected to pay a 17% premium?

CloudTag – L1 finishes loan conversion. Now for death-spiral-on-steroids warrants. Sell!

Published 154 days ago

AIM-listed CloudTag (CTAG) has announced the conversion of the final little bit of loan notes held by death spiral provider L1, at 4.5p. The shares have raced ahead, even though this only marks the half-way point in the share price carnage caused by the package. Indeed, it may not even be half, for the warrant exercise terms are far more favourable than the loan conversion terms (from L1’s perspective).

CloudTag – another L1 conversion. Has it almost finished trashing the share price? Er….

Published 155 days ago

Shares in AIM-listed purveyor of fictional guaranteed orders for fictional not guaranteed products CloudTag (CTAG) has announced the latest confetti-issue to L1 under the death-spiral loan deal. £300,000 worth of loans converted at 4.5p leaves just £100,000 left over. The shares have shot 15% higher on the news: the BB loons obviously think it’s (nearly) all over. I’ve got bad news there….

CloudTag – another L1 conversion, new bargain basement price. How long until 0p?

Published 169 days ago

AIM-listed jam the day after tomorrow company CloudTag (CTAG) has announced the latest death spiral loan conversion by L1 – this time at just 4.5p per share. Of course, for a company with no product and no orders and which has been, shall we say, economical with the actualitees that is still overvaluing the shares by 4.5p. 

CloudTag - volume spikes up, shares spike er.....down. Who's selling?

Published 176 days ago

There seems to have been quite a bit of volume yesterday in trading of AIM-listed CloudTag (CTAG). Some of us have been noting the rather greater difficulty with which L1 has been offloading stock from loan conversions and warrant exercises which goes in tandem with lower volume - and a complete lack of news from the company to get the BBs in a lather, but yesterday things really picked up. Sadly for shareholders, the share price has not been picking up, it has been on the slide.

CloudTag – when does the L1 funding package fall apart?

Published 177 days ago

Tom Winnifrith and Waseem Shakoor were commenting yesterday on where shares in AIM-listed CloudTag were heading. Obviously the end target for a company with still no working product available to sell, revenues of zero and stonking cash-burn is nil. But the focus of attention is the L1 funding package and when it could fall apart.

CloudTag – predictably another conversion by L1, but now warrants being exercised too

Published 185 days ago

This morning AIM-listed CloudTag (CTAG) has announced, predictably enough, another loan note conversion by L1. But in what looks to be a bit of a surprise move, L1 has also elected to start on the warrants too, despite there still being loan notes outstanding. But oh dear, what about the dates…..

CloudTag – Waseem Shakoor bang on the money again as L1 converts another slice at 6.5p, and what happened to Hector?

Published 197 days ago

Yesterday the bear raider Waseem Shakoor tweeted that he expected another conversion notice within 24 hours as L1 sought to offload another line of its death spiral loan funding onto AIM-listed CloudTag’s gullible shareholder base. Right on cue, this morning we learnt that the conversion notice was served yesterday, seeing L1 convert £250,000 of notes into shares at just 6.5p. That, against the current bid price of 8.5p. Having thought that my plan for great riches as an AIM death spiral financier might be fraught with danger, I wonder whether I should reconsider.

CloudTag – drawdown of final tranche L1 funding, and yet another clarification needed by Nomad Cairn?

Published 198 days ago

Two RNS announcements this morning from AIM-listed CloudTag (CTAG) this morning tell us that the company has drawn down the final amount of cash under its death spiral funding deal with L1. The problem is that the dates don’t quite work. Perhaps Nomad Cairn would care to clarify (yet again)?

CloudTag – “Fiske”ing yesterday’s “clarification” RNS: was it more an “obfuscation” RNS? Answers required from Cairn.

Published 209 days ago

The ‘fessing-up RNS of yesterday leaves a few unanswered questions – so many that I just can’t help but wonder whether what we think we are being told is not actually the same as what we are being told. Let me explain as we “Fiske” the text and wonder whether there had, in fact, been a retrospective alteration to the terms of the loan conversion and associated warrant terms.

GOTCHA CloudTag! But now tell us about the loan conversion terms

Published 210 days ago

And so AIM-listed ClieTag (oops) CloudTag (CTAG) duly ‘fessed up in the wake of my piece yesterday that it had not been telling the truth. Again. But it gets worse, as the company only dealt yesterday with hitherto undisclosed warrant exercise terms. It did still does not clear up the issue of the loan conversion terms and so, unbelievably, yet another confessional RNS statement is needed. 

CloudTag – L1 converts, company takes the piss. Will Nomad Cairn now finally walk?

Published 211 days ago

Well surprise, surprise. AIM-listed CloudTag (CTAG) gets its shares unsuspended and a few days later L1 converts another batch of loan notes, as announced in last night's no-one-is-watching o’clock RNS. OK, no great surprises so far – especially in view of the price action since the suspension was lifted. But look at the terms: has there been a a material and previously unannounced change, and if so, when?

CloudTag – trading restored as company gets back to what it does best

Published 217 days ago

Wow! I’d love to have been a fly on the wall over at Cairn Financial as the wording of last night’s no-one-is-watching-o’clock RNS from AIM-listed CloudTag (CTAG) was being, ahem, “discussed.” I wonder how long that lot took to put together….since last Friday? It was a real shocker.

CloudTag – “Fiske”ing yesterday’s RNS: WTF is going on?

Published 223 days ago

A great call from Cynical Bear appears to have forced a statement out of AIM-listed CloudTag (CTAG) and a suspension of the shares. But close reading of last night’s no-one-is-watching o’clock statement suggests that the announced loan conversion and warrant issue is not all that it seems. I’ll come back to the issue of headroom later, but first there are a few issues which need to be clarified by the company in short order. 

CloudTag – Share Issuance headroom maths looks grim, statement needed

Published 231 days ago

Oh dear. Oh dearie me. With the share price of embattled AIM-listed CloudTag (CTAG) still coming down faster than a Waseem Shakoor post on the LSE CTAG BB, the bid price has dropped to just 5.25p last seen. If my maths is right, L1’s outstanding loan notes can’t all be converted until after the forthcoming EGM (assuming that shareholders approve the relevant resolutions). Even then, it looks as though Tranche 2 is in danger of not being convertible if the bid price falls much further. Perhaps the Nomad, Cairn Financial, might wish to have the matter clarified to the market.

CloudTag – My plan for great riches hits a new snag

Published 233 days ago

Oh dear, AIM-listed jam- (and product) tomorrow (or sometime, maybe) CloudTag (CTAG) closed last night notching up (or, perhaps down) a bid price of just 6.75p per share. This might be causing a few headaches over at L1 Towers as it seeks to convert its remaining £1.2 million of convertible notes from Tranche 1 of its death spiral funding package. My plan to become a death spiral financier on the Casino seems to have hit a nasty problem – that of headroom in already existing share issuance authorities of the investee company running out and leaving me lobster-potted in unconvertible notes. Of course, I can “persuade” the company to increase the authorities, but time is of the essence: I want to offload ASAP and bank my bunce.

ValiRx – AGM update casts a shadow over company financing

Published 389 days ago

Shareholders in AIM-listed cancer-buster ValiRx (VAL) rejected a disapplication of pre-emption rights special resolution at the AGM held last Monday. The company said a further announcement would follow “in due course” but since then there has been silence. But it seems that there might be a few implications for the financing of the company going forward.

Lansdowne Oil and Gas – results, bailout package (kicking the can)

Published 398 days ago

Dublin-headquartered and AIM-listed Lansdowne Oil & Gas (LOGP) has seen its shares suspended since it announced an adverse ruling in the Court of Appeal on 13 April which left the company in need of, ahem, clarifying its financial position. This morning we had FY15 numbers which suggest that this was not the only problem, but the good news is that it is not going bust just yet: a bailout package has been put together. 

ShareProphets

About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /